Published in Women's Health Weekly, October 9th, 2003
Similar studies have been conducted in Europe with promising results (e.g., Diel et al., New England Journal of Medicine, 1998;339:357-63). The drug is approved for this indication in Canada, but not the U.S.
"We believe that cancer can spread easier and develop in bones that are damaged," said Mary Cianfrocco, DO, a medical oncologist at Fox Chase and principal investigator of this study....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly